CHLORHEXIDINE ALCOHOL FREE MOUTHWASH
Land: Kanada
Språk: engelska
Källa: Health Canada
Produktens egenskaper
(SPC)
28-07-2017
Vissa dokument för denna produkt är för närvarande inte tillgängliga, du kan skicka en begäran till vår kundservice och vi kommer att meddela dig så snart vi kan få dem.
Skicka förfrågan.
Skicka förfrågan.
Aktiva substanser:
CHLORHEXIDINE GLUCONATE
Tillgänglig från:
EURO-PHARM INTERNATIONAL CANADA INC
ATC-kod:
A01AB03
INN (International namn):
CHLORHEXIDINE
Dos:
0.12%
Läkemedelsform:
MOUTHWASH
Sammansättning:
CHLORHEXIDINE GLUCONATE 0.12%
Administreringssätt:
BUCCAL
Enheter i paketet:
500ML/4L
Receptbelagda typ:
Prescription
Terapiområde:
MISCELLANEOUS ANTI-INFECTIVES
Produktsammanfattning:
Active ingredient group (AIG) number: 0107629007; AHFS:
Bemyndigande status:
CANCELLED POST MARKET
Tillstånd datum:
2021-06-03
Produktens egenskaper
1
PRODUCT MONOGRAPH
PR
CHLORHEXIDINE ALCOHOL FREE
Chlorhexidine Gluconate Oral Rinse, 0.12% w/v House Standard
ANTIGINGIVITIS ORAL RINSE
EURO-PHARM INTERNATIONAL CANADA INC.
9400 BOUL. LANGELIER
MONTREAL, QUEBEC
H1P 3H8
DATE OF PREPARATION:
JULY 6, 2017
CONTROL NO.: 205962
2
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
SUMMARY PRODUCT INFORMATION
.......................................................................
3
INDICATIONS AND CLINICAL USE
.............................................................................
3
CONTRAINDICATIONS
..................................................................................................
3
WARNINGS AND PRECAUTIONS
.................................................................................
4
ADVERSE REACTIONS
...................................................................................................
5
DRUG INTERACTIONS
...................................................................................................
5
DOSAGE AND ADMINISTRATION
...............................................................................
5
OVERDOSAGE
.................................................................................................................
6
ACTION AND CLINICAL PHARMACOLOGY
............................................................. 7
STORAGE AND STABILITY
...........................................................................................
8
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................. 8
PART II: SCIENTIFIC INFORMATION
................................................................................
9
PHARMACEUTICAL INFORMATION
...........................................................................
9
CLINICAL TRIALS
.........................................................................................................
10
TOXICOLOGY
...................................................................................
Läs hela dokumentet
